JAM
ASMB icon

Jupiter Asset Management’s Assembly Biosciences ASMB Stock Holding History

Jupiter Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,520
Closed -$84K – 584
2021
Q1 		$84K Buy
+1,520
New +$101K ﹤0.01% 555

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Jupiter Asset Management's ASMB Position: Q2 2021 in Review

Jupiter Asset Management sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 1,520 shares — an estimated $84K sold.

Jupiter Asset Management first reported a position in ASMB in Q1 2021 and held it in 1 quarter. The position peaked at $84K in Q1 2021. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • Jupiter Asset Management reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • Jupiter Asset Management sold 1,520 Assembly Biosciences shares in Q2 2021, an estimated $84K.
  • Jupiter Asset Management first reported a position in Assembly Biosciences in Q1 2021 and held it in 1 quarter.
  • Jupiter Asset Management's Assembly Biosciences position peaked at $84K in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Jupiter Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.